Tag | Content |
---|
EnhancerAtlas ID | HS151-11572 |
Organism | Homo sapiens |
Tissue/cell | OCI-LY1 |
Coordinate | chr8:41997150-41999180 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
RFX1 | MA0509.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | + | 7.02 | RFX1 | MA0509.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | - | 7.02 | RFX2 | MA0600.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | + | 7.04 | RFX2 | MA0600.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | - | 7.28 | RFX5 | MA0510.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | - | 7.02 | RFX5 | MA0510.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | + | 7 |
|
| Number of super-enhancer constituents: 22 | ID | Coordinate | Tissue/cell |
SE_10617 | chr8:41996742-42000638 | CD19_Primary | SE_11527 | chr8:41996399-42001420 | CD20 | SE_11958 | chr8:41996681-42001675 | CD3 | SE_12998 | chr8:41996662-42001195 | CD34_Primary_RO01480 | SE_13586 | chr8:41996283-42002252 | CD34_Primary_RO01536 | SE_14125 | chr8:41996516-42001382 | CD34_Primary_RO01549 | SE_14499 | chr8:41996655-42002299 | CD4_Memory_Primary_7pool | SE_15439 | chr8:41996577-42001146 | CD4_Memory_Primary_8pool | SE_15838 | chr8:41996734-42001407 | CD4_Naive_Primary_7pool | SE_16334 | chr8:41996804-42001135 | CD4_Naive_Primary_8pool | SE_16963 | chr8:41996692-42001266 | CD4p_CD225int_CD127p_Tmem | SE_17422 | chr8:41996437-42002582 | CD4p_CD25-_CD45RAp_Naive | SE_17925 | chr8:41996376-42001954 | CD4p_CD25-_CD45ROp_Memory | SE_18335 | chr8:41996168-42006983 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19215 | chr8:41996645-42001482 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20189 | chr8:41996609-42001489 | CD56 | SE_20868 | chr8:41996560-42001475 | CD8_Memory_7pool | SE_21518 | chr8:41996610-42001381 | CD8_Naive_7pool | SE_22029 | chr8:41996575-42001644 | CD8_Naive_8pool | SE_22476 | chr8:41996473-42002144 | CD8_primiary | SE_38500 | chr8:41996634-42001102 | HUVEC | SE_62846 | chr8:41996602-42040825 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GAGATGCAAA CACACATACC ACATACACAC AGCCCTACTC ACACTCTTCT GCACTTTATT 60 ACTTAGAATA CACCGGAAAA TTTCCACGTC TCAGCAAATA CAGCTGCCCT GTACTCTTTA 120 ATGGCAGCTT AGTGTTCCCT CAGAGGGATG CGCCCCATAT CATTCACCCA GCCCCCAGGG 180 ACGGGCTTTT AGGTTGTTTC CAGCTGCTTG CTCTTACAAG CAACATTGCA ACGCTGCCCT 240 GTTACTTTTA ATCTTCTTTA TCCTGTGATT CCGTTCTGCT TTTCCTTCCA GCACGACTGC 300 AAAGTGACTG CGGGGTTTTC CCGAGTGCCC TCGCCCCAGA CCTCAGCGAG TTATTTGTGG 360 AGTCACCGGG TCCTGCTCCG CATTGTTATT CGAAGTCTCC CCGGGACAGC GGGGAGCAGG 420 CGGAGCTGCG TGTCCCGGCC TGCGCGTCTG GGCCCAGGCG GGCGCGCGTC GCGCTCGGAT 480 TTCGGGCGGA TAGTGCGTGG GAGGCGGCGC TGCCCTCCGT ATGCAGCGCG CGTGCAGCCA 540 AGGCGGCGCT GCGATCTGCG GCCTGGGGCC CTGGTGTGAA ACTCCCGCGG AGACGCTCCC 600 AGCCCCGGGC CGCAGCTCGC CCCTGCACGG AGGGAGGTGT CTAAAGGTGT CTCTTAGGAA 660 CAGGCACAAC CCGAGCAGCC GGGCCCCAGA ACAATGGGTG CTTTCAGCCG CCCCTTTAGA 720 TGCCTGGCCC GTCACCATGG CAACCACCCC ATTATTGAAA GTCAGTGCCG GTCCCCGCCT 780 TAGACGCTCT CCTCCCGGGC TCCCCTCCCC CGCCGGCCCC GCCGTATGGT GTGTGTGTCA 840 CTGGCAGCTG TTGTCAAAAG AAGGCACCTC TTTGTCTCCA GGGGATGAAA GCCATTTGGT 900 TTCCAGCGCC ACCCTTTCTC TCCGCCCGGC AACTTTTCTC CGCGTCCCGT CCCCAAGGCG 960 TCCCTGGATG CGCGCGCTCG GCCCCGCGCC CGCCACCCGC GCTGAGTGCT GGTATCCTCC 1020 CCATCACTCA GCCCAGAGCC GTTCTGCCTC TGCCTCAAAC TCTCAGAGTC CTTATAAGTC 1080 TTATTCTCAA GAGTTGTGTC CCAGCGAAGG GAATCCGCCT TGGAAATCGC GGCTTCCTCC 1140 TTGCACGCCG CTCGCTGTTT CAGCGCAAGC CGGATCTCCC CTCACACCCA ACAGCACCAC 1200 CTTCCGAGAC TAGCGGCTCA TTACCGCCCA GTCCCCGCGG CCGGCGCAAG AACTCCTCGC 1260 CGGGCCCCAT TCCAGGCTGG GTCGGGTCTT TAGAATAAGG ACCAGTTGTG TGTCTCCCTG 1320 TCGCTGGCAG CGGATCACTT TCTGGCTGAA GAAAAGACAA AACGACGAGG GAAACAATAG 1380 GACCTGTATG TTTTACACAC AGTTCTCATT CGAAATGTAT CATGATCATA TTTTTAAAGA 1440 TGCGTGTTAC CTTTCATAAA TACCTAAATA AAACTTACTT TCTGTTGTCT GCGGAGGAAC 1500 TTGATAAACA TTAAAAAAGC AAGAATATCT TTGGTGGCCA TGTGTCTGGG ATGTGGGGTT 1560 CACCTATCAT CTGCCCCAGG GATCCTAAGA GGGGAACAGA TGGTGTTTTC AAAACCTATC 1620 TGGAAATTAA AAAGGTTACG GTGCTGAGAG GAAGAGCAGA GTCCAAGAGG AGGGGGCTGT 1680 GAGAGAGAAA CGCAGAGAGA GGATAAAGCT AGGACTTCCA GTTATTCTGT AAAGACAAAC 1740 TTGAGATGCT GTGTGGGTAG GAAAAATAGA GGCGTCATAA AACTTCACTG ATACTGAAAA 1800 GTGTAACTAC TAGAGGAAGA AATTTAAGGA TAATTTGTTC AGAACTCAGT CTATATTTTC 1860 AAATAAAGTT TAAAAATAAT TACCAAATGA TAAACACATT TTTAAAACTT TGTAAATGCT 1920 AAAAGTATGA CAAGTAAAGA AAAGCAGGTG ACTGACAAGA GGTAAGTTGT TCTGGTCTTT 1980 GCTTTCAATA ACTATCCGTT CCATTTGATA AACAGGATGC AGGCGAGTCT 2030
|